Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2023-07-10EMA Withdrawn: Lenalidomide Krka d.d. (lenalidomide hydrochloride hydrate) — Krka, d.d., Novo mesto
The EMA withdrew lenalidomide hydrochloride hydrate (Krka) from the market for multiple indications including multiple myeloma, follicular l…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma [Phase 2]
Phase 2 trial evaluating daratumumab with bortezomib and dexamethasone in newly diagnosed transplant-ineligible multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma has compl…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma; the study …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients [Phase 3]
Phase 3 trial comparing Velcade, Melphalan, Prednisone and Thalidomide versus Velcade, Melphalan, Prednisone in patients with multiple myelo…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial update evaluating Revlimid (lenalidomide) and prednisone followed by Revlimid, melphalan, and prednisone in patients …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide [Phase 1, Phase 2]
Phase 1/2 trial evaluating pomalidomide with cyclophosphamide and prednisone (PCP) in patients with relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial of Delanzomib in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma has completed wi…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma [Phase 2]
Phase 2 diagnostic study evaluating CD38-targeted ImmunoPET for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone [Phase 2]
Phase 2 study evaluating the clinical benefit of lenalidomide in combination with dexamethasone for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy and peripheral stem cell transplantation in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) [Phase 1, Phase 2]
Phase 1/2 trial update for P-BCMA-101 Tscm CAR-T cells in multiple myeloma; trial status terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma [Phase 2]
Phase 2 trial evaluating VRD as induction followed by VR maintenance in newly diagnosed high-risk multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation [Phase 2]
Phase 2 clinical trial evaluating a biological therapy for multiple myeloma that recurred after bone marrow transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating ATG-010 in relapsed/refractory multiple myeloma has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without PSC 833 in relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update for LCAR-B38M cells in relapsed/refractory multiple myeloma (Phase 1/Phase 2) is provided, with unspecified status.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating melflufen in combination with daratumumab in relapsed or relapsed-refractory multiple myeloma was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial update on pomalidomide, bortezomib, and low-dose dexamethasone in relapsed or refractory multiple myeloma; results posted.
-
FDA approval · 2023-06-05FDA Approved: ZOLEDRONIC ACID — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' original application for zoledronic acid, enabling a generic IV bisphosphonate product. This mark…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: BiRd vs. Rd as Initial Therapy in Multiple Myeloma [Phase 3]
Phase 3 trial comparing BiRd versus Rd as initial therapy in multiple myeloma was terminated; results posted in 2023.
-
CLINICAL_TRIALS research · 2023-06-02Clinical Trial Update: Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients [Phase 4]
Phase 4 clinical trial investigating safety and symptom burden optimization of tocilizumab as part of ASCT conditioning for multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant [Phase 2]
Phase 2 trial evaluating lenalidomide as maintenance therapy after tandem autologous and allogeneic transplant in newly diagnosed multiple m…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on high-dose BeEAM chemotherapy with autologous transplant in multiple myeloma; study completed with results p…